Neuropsychological Evaluation for Oncology.

Cognitive dysfunction is common in cancers and their treatments. Factors that can contribute to cognitive dysfunction include direct and indirect effects of cancer, surgery, radiation, systemic therapy, as well as comorbidities, fatigue, and mood disturbance. Using objective, validated measures, a neuropsychological evaluation can provide information regarding patterns of cognitive function. Emphasis of cognitive domains assessed may vary depending on disease and treatment history. Cognitive interventions can minimize the effects of cancer-related cognitive dysfunction on daily life.
Competing Interests: Disclosure The authors do not have any commercial or financial conflicts of interests with this work. J. Wefel received consulting fees from Bayer and Intra-Cellular Therapies, and research funding (paid directly to institution) from Bayer, Germany, GT Medical Technologies, and Novocure, Israel.
(Copyright © 2024 Elsevier Inc. All rights reserved.)